Trial intelligence / Profile preview

Dexmedetomidine in Classical vs Modified TLIP Block for Lumbar Disc Surgery

NCT06690021Phase 4Not yet recruiting

Sponsor
Assiut University
Start
Dec 2024
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Total Opioid Consumption at 24 hours. Planned start Dec 2024; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06690021.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06690021.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call